NATURE’S SUNSHINE PRODUCTS, INC. Repayments of Other Long-term Debt
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Repayments of Other Long-term Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherLongTermDebt · last filed 2025-03-11
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of other long-term debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of other long-term debt for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of other long-term debt for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of other long-term debt for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of other long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of other long-term debt for fiscal 2023 was $1.17M, a 5.63% decline from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of other long-term debt for fiscal 2022 was $1.24M, a 4.75% decline from fiscal 2021.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of other long-term debt for fiscal 2021 was $1.31M, a 75.70% decline from fiscal 2020.
| Period end | Repayments of Other Long-term Debt 3 month | Repayments of Other Long-term Debt 6 month | Repayments of Other Long-term Debt 9 month | Repayments of Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $0.00 10-K · filed 2025-03-11 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $216.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $216.00K derived: sum of 3 quarters · filed 2025-03-11 | $537.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $216.00K derived: sum of 2 quarters · filed 2025-03-11 | $537.00K derived: sum of 3 quarters · filed 2025-03-11 | $856.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-12-31 | $216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $537.00K derived: sum of 2 quarters · filed 2025-03-11 | $856.00K derived: sum of 3 quarters · filed 2025-03-11 | $1.17M 10-K · filed 2025-03-11 |
| 2023-09-30 | $321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $640.00K derived: sum of 2 quarters · filed 2024-11-07 | $958.00K 10-Q · filed 2024-11-07 | $1.27M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $319.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $637.00K 10-Q · filed 2024-08-08 | $950.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.26M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $318.00K 10-Q · filed 2024-05-07 | $631.00K derived: sum of 2 quarters · filed 2024-05-07 | $944.00K derived: sum of 3 quarters · filed 2024-05-07 | $1.25M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $626.00K derived: sum of 2 quarters · filed 2024-03-12 | $936.00K derived: sum of 3 quarters · filed 2024-03-12 | $1.24M 10-K · filed 2024-03-12 |
| 2022-09-30 | $313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $623.00K derived: sum of 2 quarters · filed 2023-11-07 | $931.00K 10-Q · filed 2023-11-07 | $1.24M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $310.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $618.00K 10-Q · filed 2023-08-09 | $923.00K derived: sum of 3 quarters · filed 2023-08-09 | $1.23M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $308.00K 10-Q · filed 2023-05-09 | $613.00K derived: sum of 2 quarters · filed 2023-05-09 | $916.00K derived: sum of 3 quarters · filed 2023-05-09 | $1.22M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $608.00K derived: sum of 2 quarters · filed 2023-03-16 | $909.00K derived: sum of 3 quarters · filed 2023-03-16 | $1.31M 10-K · filed 2023-03-16 |
| 2021-09-30 | $303.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $604.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.00M 10-Q · filed 2022-11-03 | $6.38M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $698.00K 10-Q · filed 2022-08-09 | $6.07M derived: sum of 3 quarters · filed 2022-08-09 | $6.07M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $397.00K 10-Q · filed 2022-05-05 | $5.77M derived: sum of 2 quarters · filed 2022-05-05 | $5.77M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $5.37M derived: sum of 2 quarters · filed 2022-03-08 | $5.37M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |